Acquisition History NeuWave Medical has changed hands multiple times, most recently acquired by Quantum Surgical in 2026 after formerly being part of Johnson & Johnson. This signals a strategic pivot in its ownership and potential integration opportunities or transition support needs for sales conversations, especially around legacy products and cross-ecosystem capabilities.

Clinical Heritage Rooted in University of Wisconsin–Madison research with a focus on energy-based minimally invasive solutions for cancer and other conditions. This pedigree highlights potential for partnerships with academic medical centers, collaboration on clinical studies, and credibility when engaging with research-focused procurement teams.

Financial Size Revenue is in the low single-digit million range with 51–200 employees. This indicates a small-to-mid market profile with likely decision cycles driven by clinical outcomes and total cost of ownership, offering opportunities for bundled value propositions, service contracts, and price-competitive packaging.

Market Position Competes in the medical equipment space with other niche players; a recent exit to Quantum Surgical points to rising interest in robotics and advanced energy-based treatments. Sales opportunities may lie in collaborations or integrations with robotic platforms and hospital systems seeking value-focused, minimally invasive therapies.

Strategic Fit Specializes in cost-conscious, patient-outcome improvements. This aligns with expanding outpatient and hospital-at-home trends, presenting opportunities to position NeuWave devices as enabling shorter procedures, faster recoveries, and potential reductions in readmissions when tied to payer-improved economics and bundled care programs.